Bradda Head Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.
Bravo minded.
"Compare Tesla/Apple etc" what a laugh...... They have multi billion marketing budgets, SA has 4 members of staff! If you know anyone with psoriasis that has tried this product you would be buying as many shares as you possibly can, this stuff really is a miracle cure, it will succeed as more and more people see the real time results. Watch the testimonials that were not paid for, they are real people giving real results. Please sell your shares and begone and leave this to those with some vision and patience.
“Whackery” you’ve appeared out of nowhere and start slamming the Company. You’re clearly a prize prick and probably aren’t invested. I wasn’t going to do this but my order number, placed 45 mins ago, signifies we are well into the thousands right now. So do us all a favour and **** off to either ADVFN we here the rest of the ******s live or go to the OPTI boards.
On the day before the launch!
Thanks for the summary. Most helpful. Did SA say anything further about Croda progress? I’m also assuming that everything is still on for the soft launch at the end of this month?
I’m simply stunned by the downward selling here. Following a great RNS that removed all uncertainly and actually stunned us all at the brilliance of the launch date and it’s relevance, people start selling down wholesale. Nothing has changed IMHO. If it had then SA would have been duty bound to RNS. I personally see this is an opportunity to top up and I will absolutely do so as funds allow. Im hoping people see this for what it is. The traders & market makers shorting the stock in advance of the launch so they can duly mop it up at a cheap price. They did just this before and after the results of the trial. Time
To fill up if you can. GLA / DYOR
Looks like I spoke too soon in my earlier post. Great RNS delivering bang on time and what a day to launch the product. Perfect! Very happy holder.
Tomorrow is the start of Q4. SA promised a launch in Q4, I’m not suggesting it has to be the first day but it would be nice to know when. I’m not expecting crazy volumes but with all of the uncertainty around freight movement at the moment it would be comforting to get some assurances. Come on SA!
Clearly I meant to say "Q4" .....apologies, I'm getting old!
This stock seems very cheap at current levels. It amazes me that despite nothing but good news we have drifted from a stable mid 70's to low 60's. Damn those days traders and market makers! Q1 is weeks away and at best its an October launch for Axisbiotix and at worst its a December launch. Either way its revenue generation this year. I for one will be topping up as and when funds allow. GLA
Wonderful to be an investor in a company that tells the truth. No waffle and no smoke and mirrors. Always driver when they say they will. I will continue to add as and when funding allows. On the point of the Croda scaling, I think Stuart actually stated that measurement of 20k cubic metres (rather than Litres) in a number of interviews. It may well be a typo but this guy isn’t in the habit of making mistakes. GLA
As I mentioned earlier, it’s a matter of weeks since the study result were announced. Pushing the management team for news for news sake is just silly. Stuart and his team have never let us down and I’m sure he will release an update when he has one. He’s not going to make stuff up! Let the weak sellers depart. I’m in this for the long haul, the current status just means we can top up at lower prices. The sellers will regret their nervousness in the end. IMHO DYOR GLA
Clearly some very short term holders dumping nervous stock here. At this price we would be mad not to top up. Nothings changed here. Enormous potential and super cheap at today’s price. I’m topping up where funds allow me to do so. IMHO / DYOR/ GLA
I think that maybe we’ve forgotten that it’s only 5 weeks since the company delivered stunning results on the study. Of which we were all elated. SA promised to give us news on regulatory pathway and pricing as well as some insight into the other skin conditions that were tested in the trial “within 90 days” which would be by the end of August. Let’s remember that this fella doesn’t break his promises. Nothing has changed here. Still the same visionary CEO, still the same world leading scientist, still the same management team and still the same products with staggering potential. All of this clammering for news baffles me. At these low prices, brought on by nervous short term holders, I’m topping up where my funds allow me to do so. Good luck to all. IMHO, DYOR
I disagree that Stuart should be updating everytime a shareholder has a question. The rules for RNS and market comms are simple......the news needs to be material and / or price sensitive. At that point the company is legally bound to release an RNS. He stated that the Croda results on upscale would complete "by end Q2". Croda would then need to write the report and then arrange the meeting with SBTX and present it. It's the 4th July for Gods sake! Give the man a break! I am expecting a business update end July with CRODA news, regulatory approval news and pricing detail. Unti, then I will happily build and hold/ IMHO, DYOR, GLA
Stuart doing off book stock movement. From one hand to another with no drama. Institutional investors quietly building their positions. IMHO
He doesn’t claim to be a man of his word. He simply is! He’s never once given a deadline and missed it.
Welcome Br3xiUK. I can only really comment in detail on Stuart Ashman as I have met him twice at investor events and he is very impressive indeed. He has a great pedigree from the likes of Smith & Nephew plc to name but one and is very transparent and honest. He has never made a promise to the market that he has failed to deliver and that's one of the things I like about him. He is the architect of the 5 pillar strategy and impressively in AxisBiotix he redesigned the entire trial to deliver the results when COVID had everyone else standing still. He is clearly very commercially minded and strategically sound. In the case of the other members of the business, the CSO Cath O'Neil is a recognised expert in the microbiome field and is highly regarded as such. I am guessing the CFO is decent too as the cash burn is extremely low and they seem to manage that very well. The Chairman also chairs the NIHR funding committee as well as having run Medtech companies himself. The senior medical advisor ran NIHR as its CEO and advises the government on medical matters as well as having recently been on the vaccine taskforce. I don't know much about the Non Exec other than the information on the SkinBio website but I believe she's top notch too. All in all they're a pretty solid team led by what I would consider to be a safe pair of hands. Hope this helps and is all IMHO
The thing I don’t get here is that on the day of the results RNS we get a second RNS that highlights Tyndall have increased their position. INCREASED their position! They are a highly professional institutional investor and their funds are hugely successful. They see this news as de-risking and thus are happy to pay more to hold more stock. We are mostly amateurs and many can’t see the true potential here. The management team are first rate and the scientists are world renowned. I’m a very happy long term holder. IMHO, GLA
Belgrano, are you suggesting the company leaked data? That is a very serious allegation indeed!